ACHIEVING IMPACT USING OCCUPATIONAL THERAPY IN EDUCATION, FOR MARGINALISED COMMUNITIES AND IN PUBLIC HEALTH
With
Associate Professor Emma George, Program Director, Occupational Therapy
School of Allied Health Science and Practice,
The University of Adelaide &
Board Director, Occupational Therapy Australia &
Australian Delegate, World Federation of Occupational Therapists
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Adelaide | June 2025
Associate Professor Emma George is a leader in occupational therapy, fascinated by the role and importance of occupation as a right for health and well-being. Her research projects all explore the way we address health inequities among marginalised people and communities with a commitment to social and occupational justice.
She has led and collaborated in research on national policy implementation, the health and well-being of Aboriginal and Torres Strait Islander people and communities, and the recovery from exploitation and modern slavery in Australia and India.
In all of her research she am committed to learning more about occupational injustices (marginalisation, alienation, deprivation, imbalance, apartheid and dysfunction), the recognition and realisation of rights, and the response of allied health in order to promote equity and justice, culturally safe practice and trauma informed care. She is an Occupational Therapy Australia board director and serves as the elected Australian delegate to the World Federation of Occupational Therapists.
Source: Supplied
-
A clinical research career working Sponsor-side, CRO-side to Site-side
In July 2025, Paratus Clinical, a Australian provider of dedicated clinical trial services, announced the appointment of Megan Morrison as its new Chief Executive Officer, at the same time as a significant milestone as the company celebrating over a decade of impact in the clinical research space. Paratus now operates a network of five purpose-built, research-only clinics along Australia’s eastern seaboard.
-
Sharing the same goals in value-based procurement
Value-based procurement (VBP) is a journey, not a sprint. It’s about putting the patient at the centre of quality affordable healthcare through changes in procurement practices for medical technologies. Patient outcomes drive value and sustainability, not just price. The bigger picture indicates that VBP will create system cost saving through benefitting patients, rather than trying to attain the reverse – a win-win outcome.
-
Improved access to technology needed for people with Type 2 Diabetes needing insulin
The National Diabetes Services Scheme (NDSS) provides subsidised products for diabetes management; however, disparities exist in access to technology between those with Type 1 and Type 2 diabetes. While continuous glucose monitoring (CGM) devices are subsidised for Type 1, they are not available for Type 2 diabetes. ADEA advocates for equitable access to these essential tools, emphasising that all individuals with diabetes deserve the resources necessary for optimal management and reduced risk of complications. Without such technologies, many are forced to rely on finger pricking, which can be inconvenient and unsafe in settings such as the workplace and in higher education.
